286 related articles for article (PubMed ID: 16387131)
41. [Importance of adherence for efficacy of hepatitis C combined therapy].
Nožić D; Delić D; Božić M; Fabri M; Svorcan P; Konstantinović L
Srp Arh Celok Lek; 2013; 141(7-8):507-10. PubMed ID: 24073558
[TBL] [Abstract][Full Text] [Related]
42. Antiviral treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon.
Schmidt SC; Bahra M; Bayraktar S; Berg T; Schmeding M; Pratschke J; Neuhaus P; Neumann U
Dig Dis Sci; 2010 Jul; 55(7):2063-9. PubMed ID: 19798575
[TBL] [Abstract][Full Text] [Related]
43. Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization.
Foruny JR; Bárcena R; Moreno A; Blázquez J; Manzano R; Gil-Grande LA; Moreno A; Nuño J
Transplantation; 2006 Jul; 82(2):289-90. PubMed ID: 16858295
[No Abstract] [Full Text] [Related]
44. Recurrent hepatitis C virus infection and outcome after living-donor liver transplant.
Satapathy SK; Fiel MI; Vanatta JM; Del Rio Martin J; Schiano TD
Exp Clin Transplant; 2013 Dec; 11(6):522-9. PubMed ID: 23901801
[TBL] [Abstract][Full Text] [Related]
45. High adherence with a low initial ribavirin dose in combination with pegylated-IFN alpha-2a for treatment of recurrent hepatitis C after liver transplantation.
Hörnfeldt E; Gjertsen H; Weiland O
Scand J Infect Dis; 2008; 40(3):259-65. PubMed ID: 17852932
[TBL] [Abstract][Full Text] [Related]
46. Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation.
Cicinnati VR; Iacob S; Klein CG; Baba HA; Sotiropoulos GC; Hilgard P; Erim Y; Broelsch CE; Gerken G; Beckebaum S
Aliment Pharmacol Ther; 2007 Jul; 26(2):291-303. PubMed ID: 17593075
[TBL] [Abstract][Full Text] [Related]
47. Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin.
Stanca CM; Fiel MI; Kontorinis N; Agarwal K; Emre S; Schiano TD
Transplantation; 2007 Jul; 84(2):180-6. PubMed ID: 17667809
[TBL] [Abstract][Full Text] [Related]
48. Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients.
Ebner N; Wanner C; Winklbaur B; Matzenauer C; Jachmann CA; Thau K; Fischer G
Addict Biol; 2009 Apr; 14(2):227-37. PubMed ID: 19291011
[TBL] [Abstract][Full Text] [Related]
49. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy.
Neff GW; Montalbano M; O'Brien CB; Nishida S; Safdar K; Bejarano PA; Khaled AS; Ruiz P; Slapak-Green G; Lee M; Nery J; De Medina M; Tzakis A; Schiff ER
Transplantation; 2004 Nov; 78(9):1303-7. PubMed ID: 15548967
[TBL] [Abstract][Full Text] [Related]
50. Sustained clearance of serum hepatitis C virus-RNA independently predicts long-term survival in liver transplant patients with recurrent hepatitis C.
Kornberg A; Küpper B; Tannapfel A; Thrum K; Bärthel E; Habrecht O; Settmacher U
Transplantation; 2008 Aug; 86(3):469-73. PubMed ID: 18698252
[TBL] [Abstract][Full Text] [Related]
51. Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome.
Selzner N; Renner EL; Selzner M; Adeyi O; Kashfi A; Therapondos G; Girgrah N; Herath C; Levy GA; Lilly L
Transplantation; 2009 Nov; 88(10):1214-21. PubMed ID: 19935376
[TBL] [Abstract][Full Text] [Related]
52. Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient.
Montalbano M; Pasulo L; Sonzogni A; Remuzzi G; Colledan M; Strazzabosco M
J Clin Gastroenterol; 2007 Feb; 41(2):216-20. PubMed ID: 17245223
[TBL] [Abstract][Full Text] [Related]
53. Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and body mass index.
Testino G; Gentile R; Ansaldi F; Borro P; Ravetti G; Icardi G; Sumberaz A
Panminerva Med; 2009 Jun; 51(2):135-6. PubMed ID: 19776716
[No Abstract] [Full Text] [Related]
54. Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.
Xirouchakis E; Triantos C; Manousou P; Sigalas A; Calvaruso V; Corbani A; Leandro G; Patch D; Burroughs A
J Viral Hepat; 2008 Oct; 15(10):699-709. PubMed ID: 18673428
[TBL] [Abstract][Full Text] [Related]
55. Sustained resolution of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy.
Bolkhir A; Brunt EM; Solomon HS; Hayashi PH
Liver Transpl; 2007 Feb; 13(2):309-11; author reply 312. PubMed ID: 17260390
[No Abstract] [Full Text] [Related]
56. Successful Hepatitis C Eradication With Preservation of Renal Function in a Liver/kidney Transplant Recipient Using Pegylated Interferon and Ribavirin.
Mukherjee S; Ariyarantha K
Transplantation; 2007 Nov; 84(10):1374-5. PubMed ID: 18049127
[No Abstract] [Full Text] [Related]
57. Long-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients.
Kornberg A; Hommann M; Tannapfel A; Wagner T; Grube T; Schotte U; Voigt R; Scheele J
Am J Transplant; 2001 Nov; 1(4):350-5. PubMed ID: 12099379
[TBL] [Abstract][Full Text] [Related]
58. HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirin.
Hakim W; Sheikh S; Inayat I; Caldwell C; Smith D; Lorber M; Friedman A; Jain D; Bia M; Formica R; Mehal W
J Clin Gastroenterol; 2009; 43(5):477-81. PubMed ID: 19142165
[TBL] [Abstract][Full Text] [Related]
59. Treatment of recurrent hepatitis C.
Gane E
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S28-37. PubMed ID: 12362295
[TBL] [Abstract][Full Text] [Related]
60. [Treatment of recurrent hepatitis C virus infection after liver transplantation].
Lengyel G; Tulassay Z
Orv Hetil; 2007 Oct; 148(40):1875-81. PubMed ID: 17905682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
